| Document |
Document Title |
|
JP4308527B2 |
The invention incorporates new processes for the chemical modification of carbon nanotubes. Such processes involve the derivatization of multi- and single-wall carbon nanotubes, including small diameter (ca. 0.7 nm) single-wall carbon na...
|
|
JP4305578B2 |
|
|
JP4295357B2 |
The invention provides a compound of the formula wherein X is S, O, NR' where R' is H or alkyl of 1 to 6 carbons, or X is ÄC(R1)2Ün where R1 is independently H or alkyl of 1 to 6 carbons, and n is an integer between 0 and 2; R2 is hydr...
|
|
JP4295361B2 |
Aryl-substituted and aryl and (3-oxo-1-propenyl)-substituted benzopyran, benzothiopyran, 1,2-dihydroquinoline, and 5,6-dihydronaphthalene derivatives have retinoid negative hormone and/or antagonist-like biological activities. The invent...
|
|
JP2009149868A |
To provide an azo compound for an anisotropic film having absorption mainly in a short wavelength area useful for a polarizing film allowing a wide range of color expression.This azo compound for the anisotropic film has the maximum abso...
|
|
JP2009149645A |
To provide a cosmetic composition and a pharmaceutical composition.The new compound displays retinoid-like dermal activity, including release of HB-EGF (heparin-binding epidermal growth factor) from keratinocytes, cell proliferation and ...
|
|
JP2009137954A |
To provide a temperature-stable labeling reagent.A temperature-stable labeling reagent of the formula is provided, wherein R1 represents H or an alkyl, aryl or substituted aryl group; R2 represents a detectable marker or at least two det...
|
|
JP2009132641A |
To provide a monomolecular azo compound having metallic luster.The method for producing the azo compound comprises a first step for diazotizing p-aminophenol, a second step for subjecting the diazo compound to a coupling reaction to synt...
|
|
JPWO2007083652A1 |
Provided is a compound having an excellent electron transporting ability, which is useful for applications such as an electrophotographic photosensitive member and an organic EL. Further, by using such a novel organic material as a charg...
|
|
JP2009102436A |
To provide a novel intermediate in the synthesis of non-nucleoside reverse transcriptase inhibitors active against HIV-1 and having an improved resistance and pharmacokinetic profile.This intermediate is a compound represented by any one...
|
|
JP4258695B2 |
O-(perfluoroalkyl)dibenzofuranium salt derivatives represented by the following general formula (1), (wherein Rf in said general formula (1) is a C1-10 perfluoroalkyl group and X<-> is a conjugate base of a Brönsted acid). Intermediates...
|
|
JP4244243B2 |
A polyazo compound capable of effectively absorbing near-infrared rays, which can be produced from readily available raw materials is provided, which comprises at least one -OH group or at least one group derived from -OH group at p-posi...
|
|
JP4226672B2 |
Ionic compound is claimed which contains at least one A<+>X<-> group in which A<+> is cation selected from biaryliodonium, arylsulphonium, arylacylsulphonium, diazonium, and organometallic cations containing transition metal complexed by...
|
|
JP4217154B2 |
The invention relates to a method for production of azo compounds. In particular the invention relates to a step-wise method for production of an azo compound, by seeding and oxidation of the corresponding hydrazoic compound.
|
|
JP4200212B2 |
|
|
JP2008545659A |
A compound having the general formula shown below: where R1-6 are independently selected from the group consisting of an electron withdrawing group, an alkyl group, an aryl group, hydrogen, a heteroaryl group, and a five or six member ri...
|
|
JP2008545655A |
This invention provides a prodrug that help arthritis patients without increasing cardiovascular and gastrointestinal risk. A novel group of hybrid nitric oxide-releasing non-steroidal anti-inflammatory drugs (NO-NSAIDs), moiety attached...
|
|
JP2008540586A |
The invention relates to non-peptidic molecules which modulate, especially inhibit, the interaction of protein kinase A (PKA) and A kinase anchor proteins (AKAP) and to a host or target organism that comprises said non-peptidic compounds...
|
|
JP2008280255A |
To provide a refractive index-converting material which provides a large variation of the refractive index and can form a film with ease.The refractive index-converting material is produced by linking a calixarene trimer compound obtaine...
|
|
JP2008280346A |
To make it possible to treat or prevent against toxicity induced in a mammal by a retinoid, vitamin A, and a vitamin A precursor, to prevent or alleviate harmful or undesirable side effects in treating a mammal with retinoids, to enhance...
|
|
JP4184435B2 |
Inhibitors of oleamide hydrolase, responsible for the hydrolysis of an endogenous sleep-inducing lipid (1, cis-9-octadecenamide) were designed and synthesized. The most potent inhibitors possess an electrophilic carbonyl group capable of...
|
|
JP4163946B2 |
The invention provides an active pharmaceutical ingredient comprising a compound of Formula II: where R 9 , R 10 and R 11 are independently selected from hydrogen and C 1 to C 4 alkyl; and R 12 is selected from hydrogen and -C(O)R 13 , w...
|
|
JP4144910B2 |
Curable dichroitic cpds. of formula (I) are new; in which A<1>, A<2> = curable mesogenic gps.; A<3> = a dichroitic gp. Also claimed are curable liquid crystalline (LC) mixts. contg. at least 2 components, at least 1 of which is a cpd. (I).
|
|
JP4127878B2 |
Preparation of a 2,3-di-substituted 4-hydroxyaniline of formula (I) comprises (a) reacting a 2,3-disubstituted phenol of formula (I) with a diazonium salt of formula (III) to give an azo compound of formula (IV); and (b) reducing (IV) to...
|
|
JP4116109B2 |
A liquid crystalline compound having a novel structure and a process for producing the same are provided. The liquid crystalline compound is represented by the following general formula (I): wherein R1 and R2 each independently represent...
|
|
JP2008150296A |
To provide a short process for producing a tetrasubstituted pyrrolidine compound without using toxic hydrocyanic acid by employing a cleavage reaction of selectively cleaving an epoxy ring, and an intermediate for producing the same.The ...
|
|
JP4105821B2 |
|
|
JP4093371B2 |
A phenylazomethylene-cyclohexadienone derivative and an electrophotographic photoreceptor include a compound that is represented by the following formula: wherein R1 and R2 are independently selected from the group consisting of a substi...
|
|
JP4092739B2 |
|
|
JP4083422B2 |
|
|
JP2008503536A |
Method for preparing gaseous diazoalkanes (I) in which a diazoalkane precursor (II), in a first solvent, and a base, in a second solvent, are reacted, and the (I) formed is removed from the reactor under reduced pressure.
|
|
JP4043046B2 |
PCT No. PCT/EP95/01233 Sec. 371 Date Mar. 6, 1997 Sec. 102(e) Date Mar. 6, 1997 PCT Filed Apr. 4, 1995 PCT Pub. No. WO95/30641 PCT Pub. Date Nov. 16, 1995New compounds and their compositions having anti-inflammatory, analgesic and anti-t...
|
|
JP2007326846A |
To provide a new material maintaining stable absorption spectra for a long period and emitting stable fluorescence. The new material is an azobenzene derivative of the general formula(I) [wherein, R1is H or the like; Ar1and Ar2are each a...
|
|
JP2007536399A |
In one aspect, the present invention provides a hyperpolarizable organic chromophore. The chromophore is a nonlinear optically active compound that includes a pi-donor conjugated to a pi-acceptor through a pi-electron conjugated bridge. ...
|
|
JP2007525494T6 |
The present invention provides ヘパラナーゼ inhibitor suitable for medical treatment of diseases which originate or relate to the catalyst activity of ヘパラナーゼ, such as cancer, an inflammatory obstacle, and an autoimmune ...
|
|
JP4016301B2 |
|
|
JP2007275742A |
To provide a method for manufacturing a water-repellent base material constituted by forming a water-repellent thin film on a base material etc., and to provide a method for manufacturing a photo processing base material having a hydroph...
|
|
JP3998279B2 |
|
|
JP3991222B2 |
A chemical amplification type resist composition comprising a specific sulfonyldiazomethane containing long-chain alkoxyl groups has many advantages including improved resolution, improved focus latitude, minimized line width variation o...
|
|
JP3988963B2 |
Ionic compound is claimed which contains at least one A<+>X<-> group in which A<+> is cation selected from biaryliodonium, arylsulphonium, arylacylsulphonium, diazonium, and organometallic cations containing transition metal complexed by...
|
|
JP3980127B2 |
|
|
JPWO2005070875A1 |
In the present invention, an imine compound and a nucleophilic compound (excluding trialkylsilyl vinyl ethers) are subjected to the general formula (1) [Chemical formula 1].(In the formula, A1Indicates a spacer, X1And X2Independently ind...
|
|
JP2007525494A |
The invention provides heparanase inhibitors suitable for treatment of diseases and disorders caused by or associated with heparanase catalytic activity such as cancer, inflammatory disorders and autoimmune diseases.
|
|
JP2007523900A |
This invention relates to compositions comprising carbon-based diazeniumdiolates attached to hydrophobic polymers that releases nitric oxide (NO). The carbon-based diazeniumdiolated polymers release NO spontaneously under physiological c...
|
|
JP3963979B2 |
To make it possible to easily and inexpensively manufacture a polarizing element (plate) with which the precise and fine control of the axis of polarization to arbitrary directions is possible and which exhibits high polarization charact...
|
|
JP3963523B2 |
To safely produce a diazo compound useful as an intermediate raw material for agrochemicals and medicines in high yield at a low cost by reacting a specific compound in the presence of a sulfonyl azide compound, etc. A compound represent...
|
|
JP3954885B2 |
To provide a quinone derivative having excellent solubility in organic solvents and compatibility with resin binders to be used, and further having excellent light sensitivity, and to provide an organic photosensitive material for electr...
|
|
JP3953096B2 |
This invention is directed to compounds of formula (I), wherein R<1> is an optionally substituted lower alkyl group; R<2> is an optionally substituted oxaaliphatic group; R<3> is an optionally substituted aryl group or an optionally subs...
|
|
JP3946995B2 |
To provide an electrolytic cell enabling the preparation of compounds with a high yield, selectivity and space time yield, which has a relatively simple structure compared to divided cells. The electrolytic cell comprises two single elec...
|
|
JP3937496B2 |
To obtain the subject new compound having high-temperature activity, excellent in solubility to an organic solvent, having high melting point and high capability of polymerization, and useful as a polymerization initiator. This compound ...
|
